Intra-uterine growth retardation and maternal labetatol treatment in a random allocation controlled study

Journal of Obstetrics and Gynaecology

Volumn 12, Issue 4, 1992, Pages 223-227

  Cruickshank, D J ^a,b   Campbell, D ^a,b   Robertson, A A ^a,b   Macgillivray, I ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LABETALOL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; FETUS GROWTH; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; PERINATAL MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0026687703     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.3109/01443619209004032     Document Type: Article

References (21)

1. Atenolol in essential hypertension during pregnancy
2. British births 1970, 2
3. Maternal obstetric outcome measures in a randomised controlled study of labetalol in the treatment of hypertension in pregnancy
4. Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study
5. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol
6. Labetalol: a combined alpha- and beta-blocker in hypertension of pregnancy
7. Acute effect of an antihypertensive drug, labetalol, on uteroplacental blood flow
8. Pregnancy hypertension—is it a disease?
9. Effects of pregnancy hypertension on the fetus
10. Scottish Perinatal Mortality Survey
11. The evaluation of labetalol in the treatment of hypertension complicating pregnancy
12. A comparison of labetalol with antihypertensive drugs in the treatment of hypertensive disease of pregnancy
13. Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the uteroplacental blood flow
14. The fetal outcome in a randomised double-blind controlled trial of labetalol versus placebo in pregnancy induced hypertension
15. Long-term propranolol therapy in pregnancy: maternal and fetal outcome
16. Fetal outcome in trial of antihypertensive treatment in pregnancy
17. A controlled trial of the treatment of hypertension in pregnancy: labetalol compared with methyldopa
18. A comparison of labetalol plus hospitalisation versus hospitalisation alone in the management of pre-eclampsia remote from term
19. Propranolol in hypertension during pregnancy
20. The assessment of fetal growth
21. Acute hemodynamic effect and cardioselectivity of acebutalol, practolol and propranolol